Black Diamond Therapeutics Ownership 2024 | Who Owns Black Diamond Therapeutics Now?
Institutional Ownership
89.77%
Insider Ownership
2.33%
Retail Ownership
7.91%
Institutional Holders
92.00
Black Diamond Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 20.58% | 0.03% | 10,659,730 | 3,934,365 | 58.50% | 49,675,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 16.44% | 0.65% | 8,517,839 | - | - | 39,693,130 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 8.59% | 1.56% | 4,448,757 | - | - | 20,731,208 | Jun 30, 2024 |
| BLACKROCK INC. | 6.21% | 0.00% | 3,217,128 | 1,836,606 | 133.04% | 14,991,815 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.11% | 0.00% | 2,131,624 | 226,324 | 11.88% | 9,933,367 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.05% | 0.73% | 2,100,000 | 2,100,000 | 100.00% | 9,786,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 3.09% | 0.76% | 1,603,200 | - | - | 7,470,912 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.02% | 0.12% | 1,046,517 | - | - | 4,876,769 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.94% | 0.00% | 1,004,878 | 458,641 | 83.96% | 4,682,731 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.63% | 0.00% | 842,432 | 459,819 | 120.18% | 3,926,177 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 1.61% | 2.32% | 835,000 | 835,000 | 100.00% | 3,891,100 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.57% | 0.00% | 813,066 | 813,066 | 100.00% | 3,790,000 | Jun 30, 2024 |
| INVESCO LTD. | 1.38% | 0.00% | 712,382 | 712,382 | 100.00% | 3,319,700 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.36% | 0.07% | 703,283 | -13,900 | -1.94% | 3,277,299 | Jun 30, 2024 |
| STATE STREET CORP | 1.33% | 0.00% | 690,432 | 573,348 | 489.69% | 3,217,413,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.30% | 0.92% | 674,198 | 674,198 | 100.00% | 3,141,763 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.25% | 0.35% | 650,000 | 650,000 | 100.00% | 3,029,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.17% | 0.03% | 605,901 | - | - | 2,823,499 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.14% | 0.02% | 588,628 | 473,052 | 409.30% | 2,743,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.98% | 0.12% | 506,000 | - | - | 2,357,960 | Jun 30, 2024 |
Black Diamond Therapeutics's largest institutional shareholder is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., holding 20.58% of the company's total share outstanding, currently valued at $49.67M. The top 10 institutional shareholders own together 68.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLY BRIDGE GROUP (NY) LLC | 1.61% | 2.32% | 835,000 | 835,000 | 100.00% | 3,891,100 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 8.59% | 1.56% | 4,448,757 | - | - | 20,731,208 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.30% | 0.92% | 674,198 | 674,198 | 100.00% | 3,141,763 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 3.09% | 0.76% | 1,603,200 | - | - | 7,470,912 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.05% | 0.73% | 2,100,000 | 2,100,000 | 100.00% | 9,786,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 16.44% | 0.65% | 8,517,839 | - | - | 39,693,130 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.25% | 0.35% | 650,000 | 650,000 | 100.00% | 3,029,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.02% | 0.12% | 1,046,517 | - | - | 4,876,769 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.98% | 0.12% | 506,000 | - | - | 2,357,960 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.20% | 0.10% | 105,039 | 105,039 | 100.00% | 489,482 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.59% | 0.09% | 303,706 | 46,706 | 18.17% | 1,415,270 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 0.18% | 0.08% | 95,000 | -30,000 | -24.00% | 442,700 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.36% | 0.07% | 703,283 | -13,900 | -1.94% | 3,277,299 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.09% | 0.04% | 48,110 | -519 | -1.07% | 224,193 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 20.58% | 0.03% | 10,659,730 | 3,934,365 | 58.50% | 49,675,000 | Jun 30, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.03% | 0.03% | 16,215 | - | - | 75,562 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.07% | 0.03% | 35,583 | 35,583 | 100.00% | 165,817 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.17% | 0.03% | 605,901 | - | - | 2,823,499 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.08% | 0.02% | 39,000 | 5,303 | 15.74% | 181,740 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.33% | 0.02% | 173,000 | - | - | 806,180 | Jun 30, 2024 |
The largest Black Diamond Therapeutics shareholder by % of total assets is ALLY BRIDGE GROUP (NY) LLC. The company owns 835.00K shares of Black Diamond Therapeutics (BDTX), representing 2.32% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 20.58% | 0.03% | 10,659,730 | 3,934,365 | 58.50% | 49,675,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.05% | 0.73% | 2,100,000 | 2,100,000 | 100.00% | 9,786,000 | Jun 30, 2024 |
| BLACKROCK INC. | 6.21% | 0.00% | 3,217,128 | 1,836,606 | 133.04% | 14,991,815 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 1.61% | 2.32% | 835,000 | 835,000 | 100.00% | 3,891,100 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.57% | 0.00% | 813,066 | 813,066 | 100.00% | 3,790,000 | Jun 30, 2024 |
| INVESCO LTD. | 1.38% | 0.00% | 712,382 | 712,382 | 100.00% | 3,319,700 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.30% | 0.92% | 674,198 | 674,198 | 100.00% | 3,141,763 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.25% | 0.35% | 650,000 | 650,000 | 100.00% | 3,029,000 | Jun 30, 2024 |
| STATE STREET CORP | 1.33% | 0.00% | 690,432 | 573,348 | 489.69% | 3,217,413,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.14% | 0.02% | 588,628 | 473,052 | 409.30% | 2,743,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.63% | 0.00% | 842,432 | 459,819 | 120.18% | 3,926,177 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.94% | 0.00% | 1,004,878 | 458,641 | 83.96% | 4,682,731 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.11% | 0.00% | 2,131,624 | 226,324 | 11.88% | 9,933,367 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.51% | 0.00% | 266,312 | 195,464 | 275.89% | 1,241,014 | Jun 30, 2024 |
| MORGAN STANLEY | 0.42% | 0.00% | 216,328 | 157,430 | 267.29% | 1,008,088 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 122,003 | 122,003 | 100.00% | 568,534 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.21% | 0.00% | 108,959 | 108,959 | 100.00% | 507,749 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.20% | 0.10% | 105,039 | 105,039 | 100.00% | 489,482 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.18% | 0.00% | 94,537 | 94,537 | 100.00% | 440,543 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.39% | 0.00% | 200,044 | 88,378 | 79.14% | 932,395 | Jun 30, 2024 |
As of Jun 30 2024, Black Diamond Therapeutics's largest institutional buyer is T. ROWE PRICE INVESTMENT MANAGEMENT, INC.. The company purchased 3.93M stocks of BDTX, valued at $49.67M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,525,754 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -878,286 | -100.00% | - | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | - | - | - | -695,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.12% | - | 63,120 | -270,128 | -81.06% | 294,139 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.24% | 0.00% | 125,250 | -203,656 | -61.92% | 583,665 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.35% | 0.00% | 183,227 | -174,837 | -48.83% | 853,838 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -170,510 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.05% | 0.00% | 25,351 | -146,025 | -85.21% | 118,136 | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | - | 25,886 | -141,360 | -84.52% | 121,000 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -125,094 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.02% | 0.00% | 12,416 | -107,044 | -89.61% | 57,859 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.04% | 0.01% | 19,116 | -75,284 | -79.75% | 89,081 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -63,866 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.24% | 0.00% | 123,034 | -49,595 | -28.73% | 573,338 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -43,699 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -38,468 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -37,145 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -34,921 | -100.00% | - | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 0.18% | 0.08% | 95,000 | -30,000 | -24.00% | 442,700 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -29,050 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Black Diamond Therapeutics's biggest institutional seller is RA CAPITAL MANAGEMENT, L.P.. The company sold -3.53M shares of BDTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 4.05% | 0.73% | 2,100,000 | 2,100,000 | 100.00% | 9,786,000 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 1.61% | 2.32% | 835,000 | 835,000 | 100.00% | 3,891,100 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.57% | 0.00% | 813,066 | 813,066 | 100.00% | 3,790,000 | Jun 30, 2024 |
| INVESCO LTD. | 1.38% | 0.00% | 712,382 | 712,382 | 100.00% | 3,319,700 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.30% | 0.92% | 674,198 | 674,198 | 100.00% | 3,141,763 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 1.25% | 0.35% | 650,000 | 650,000 | 100.00% | 3,029,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 122,003 | 122,003 | 100.00% | 568,534 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.21% | 0.00% | 108,959 | 108,959 | 100.00% | 507,749 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.20% | 0.10% | 105,039 | 105,039 | 100.00% | 489,482 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.12% | 0.00% | 60,189 | 60,189 | 100.00% | 280,481 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | 0.00% | 50,000 | 50,000 | 100.00% | 233,000 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.09% | 0.00% | 46,400 | 46,400 | 100.00% | 37,120 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.07% | 0.03% | 35,583 | 35,583 | 100.00% | 165,817 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.06% | - | 28,593 | 28,593 | 100.00% | 138,962 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.06% | 0.00% | 28,501 | 28,501 | 100.00% | 133,000 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.04% | 0.00% | 23,146 | 23,146 | 100.00% | 108,000 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.04% | - | 22,388 | 22,388 | 100.00% | 104,328 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.04% | 0.00% | 21,300 | 21,300 | 100.00% | 99,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 19,984 | 19,984 | 100.00% | 93,325 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.04% | - | 18,600 | 18,600 | 100.00% | 86,676 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | - | 17,340 | 17,340 | 100.00% | 80,804 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.01% | 16,814 | 16,814 | 100.00% | 78,000 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.03% | 0.00% | 16,260 | 16,260 | 100.00% | 75,772 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 12,893 | 12,893 | 100.00% | 60,081 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 9,729 | 9,729 | 100.00% | 45,337 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 3,825 | 3,825 | 100.00% | 17,748 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 3,639 | 3,639 | 100.00% | 16,958 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 2,691 | 2,691 | 100.00% | 12,540 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 1,285 | 1,285 | 100.00% | 6,000 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.00% | 400 | 400 | 100.00% | 1,864 | Jun 30, 2024 |
Black Diamond Therapeutics's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 2.10M shares, valued at $9.79M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -3,525,754 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -878,286 | -100.00% | - | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | - | - | - | -695,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -170,510 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -125,094 | -100.00% | - | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -63,866 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -43,699 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -38,468 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -37,145 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -34,921 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -29,050 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -27,586 | -100.00% | - | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | - | -24,500 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -23,635 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -21,200 | -100.00% | - | Jun 30, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | - | - | - | -21,011 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -16,218 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -12,416 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -11,032 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -11,000 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -10,912 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -10,361 | -100.00% | - | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | - | - | - | -10,243 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,182 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -107 | -100.00% | - | Jun 30, 2024 |
| TSFG, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
Black Diamond Therapeutics's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -3.53M shares, valued at -, as of undefined.
Black Diamond Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.31% | 833,550 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.31% | 1,127,164 | 1,127,164 | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.29% | 2,314,800 | -2,400 | -0.10% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.14% | 294,162 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.11% | 90,404 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.09% | 18,150 | - | - | Mar 28, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.09% | 41,586 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.07% | 165,800 | -19,000 | -10.28% | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.06% | 141,558 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 27,000 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 428,061 | - | - | Jan 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.04% | 23,500 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.04% | 725,952 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.04% | 405,544 | 405,544 | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 75,957 | - | - | Feb 29, 2024 |
| ALGER FUNDS | 0.02% | 16,617 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 127,800 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 16,600 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 95,527 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 22,300 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 46,156 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 525,000 | - | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.01% | 158,600 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 61,090 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,653 | - | - | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.01% | 11,800 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 23,178 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,846,239 | -721,120 | -28.09% | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 50,030 | 50,030 | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 267,347 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 151,019 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 158,400 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 19,700 | - | - | Mar 31, 2024 |
| FIDELITY PURITAN TRUST | 0.00% | 104,684 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 1,678 | 61 | 3.77% | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 201,600 | 37,036 | 22.51% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 117,490 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 377 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 337,624 | 47,163 | 16.24% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 72,100 | - | - | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 22,583 | -16,422 | -42.10% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 16,611 | - | - | Dec 31, 2023 |
| FINANCIAL INVESTORS TRUST | 0.00% | 62,997 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 1,218 | 1,218 | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 137,300 | - | - | Feb 29, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 30,208 | - | - | Mar 28, 2024 |
| Direxion Shares ETF Trust | 0.00% | 100,380 | - | - | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,730 | - | - | Mar 28, 2024 |
| SEASONS SERIES TRUST | 0.00% | 15,275 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,175 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,541 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,273 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 16,394 | -1,874 | -10.26% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 14,484 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 17,510 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 149 | - | - | Apr 30, 2021 |
| VANGUARD WORLD FUND | 0.00% | 69,377 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 9,443 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 21,359 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,956 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 29,968 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 4,143 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 6,000 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 397 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 6,341 | - | - | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 4,540 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,800 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 164,000 | - | - | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 5,530 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 70,745 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,489 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,218 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 936 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 33,739 | 33,623 | 28985.34% | Jan 31, 2024 |
| FIDELITY INVESTMENT TRUST | 0.00% | 12,500 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 307 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 5,153 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 217 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 487 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,162 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 158,582 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,510,204 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 77,830 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 32,083 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 120 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 8,442 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 653 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 27,640 | 10,459 | 60.88% | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,038 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 135 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,983 | 1,017 | 25.64% | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 6,367 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 46,260 | 8,322 | 21.94% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 582 | - | - | Mar 28, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 10,447 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 22 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 18,945 | -10,830 | -36.37% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 16,016 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 51,610 | - | - | Dec 31, 2023 |
Black Diamond Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 833.55K shares, compromising 0.31% of its total assets.
Black Diamond Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | 3.37% |
| 31 Mar, 24 | 89 | 15.58% |
| 31 Dec, 23 | 77 | - |
| 30 Sep, 23 | 77 | -3.75% |
| 30 Jun, 23 | 80 | 60.00% |
| 31 Mar, 23 | 50 | -15.25% |
| 31 Dec, 22 | 59 | -4.84% |
| 30 Sep, 22 | 62 | - |
| 30 Jun, 22 | 62 | -16.22% |
| 31 Mar, 22 | 74 | -15.91% |
| 31 Dec, 21 | 88 | -10.20% |
| 30 Sep, 21 | 98 | -4.85% |
| 30 Jun, 21 | 103 | -11.97% |
| 31 Mar, 21 | 117 | 6.36% |
| 31 Dec, 20 | 110 | 25.00% |
| 30 Sep, 20 | 88 | 10.00% |
| 30 Jun, 20 | 80 | 23.08% |
| 31 Mar, 20 | 65 | 6400.00% |
| 31 Dec, 19 | 1 | - |
As of 30 Jun 24, 92 institutions are holding Black Diamond Therapeutics's shares, representing an increase of 3.37% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 46,506,845 | 18.77% |
| 31 Mar, 24 | 39,156,127 | 2.72% |
| 31 Dec, 23 | 38,119,952 | 2.48% |
| 30 Sep, 23 | 37,195,825 | -8.55% |
| 30 Jun, 23 | 40,672,278 | 89.24% |
| 31 Mar, 23 | 21,491,972 | 2.08% |
| 31 Dec, 22 | 21,053,327 | -2.02% |
| 30 Sep, 22 | 21,488,446 | -0.06% |
| 30 Jun, 22 | 21,500,290 | -6.07% |
| 31 Mar, 22 | 22,889,468 | -1.33% |
| 31 Dec, 21 | 23,199,077 | -4.83% |
| 30 Sep, 21 | 24,375,326 | -4.03% |
| 30 Jun, 21 | 25,397,606 | -12.73% |
| 31 Mar, 21 | 29,102,784 | 1.70% |
| 31 Dec, 20 | 28,616,613 | 20.42% |
| 30 Sep, 20 | 23,763,219 | 2.71% |
| 30 Jun, 20 | 23,135,681 | 3.82% |
| 31 Mar, 20 | 22,285,068 | 220982.02% |
| 31 Dec, 19 | 10,080 | - |
Black Diamond Therapeutics (BDTX) has 46.51M shares outstanding as of 30 Jun 24, up 18.77% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 89.77% | 1.13% |
| 31 Mar, 24 | 89.08% | 1.59% |
| 31 Dec, 23 | 74.83% | 0.72% |
| 30 Sep, 23 | 101.86% | 0.82% |
| 30 Jun, 23 | 111.48% | 3.21% |
| 31 Mar, 23 | 58.91% | 1.76% |
| 31 Dec, 22 | 57.86% | 1.66% |
| 30 Sep, 22 | 59.12% | 1.68% |
| 30 Jun, 22 | 59.24% | 1.49% |
| 31 Mar, 22 | 63.11% | 1.54% |
| 31 Dec, 21 | 64.11% | 1.42% |
| 30 Sep, 21 | 67.30% | 1.37% |
| 30 Jun, 21 | 70.19% | 1.08% |
| 31 Mar, 21 | 80.57% | 1.07% |
| 31 Dec, 20 | 86.96% | 1.99% |
| 30 Sep, 20 | 66.14% | 1.59% |
| 30 Jun, 20 | 64.43% | 0.73% |
| 31 Mar, 20 | 94.03% | 9852877.02% |
| 31 Dec, 19 | 0.03% | - |
As of 30 Jun 24, Black Diamond Therapeutics is held by 89.77% institutional shareholders, representing a 1.13% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 55 | 10.00% |
| 31 Mar, 24 | 50 | 31.58% |
| 31 Dec, 23 | 38 | - |
| 30 Sep, 23 | 38 | -19.15% |
| 30 Jun, 23 | 47 | 487.50% |
| 31 Mar, 23 | 8 | -61.90% |
| 31 Dec, 22 | 21 | - |
| 30 Sep, 22 | 21 | 16.67% |
| 30 Jun, 22 | 18 | -47.06% |
| 31 Mar, 22 | 34 | -10.53% |
| 31 Dec, 21 | 38 | 11.76% |
| 30 Sep, 21 | 34 | -46.03% |
| 30 Jun, 21 | 63 | 6.78% |
| 31 Mar, 21 | 59 | -23.38% |
| 31 Dec, 20 | 77 | 35.09% |
| 30 Sep, 20 | 57 | 14.00% |
| 30 Jun, 20 | 50 | -23.08% |
| 31 Mar, 20 | 65 | 6400.00% |
| 31 Dec, 19 | 1 | - |
55 institutional shareholders have increased their position in BDTX stock as of 30 Jun 24 compared to 50 in the previous quarter (a 10.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -18.18% |
| 31 Mar, 24 | 22 | 10.00% |
| 31 Dec, 23 | 20 | 17.65% |
| 30 Sep, 23 | 17 | 13.33% |
| 30 Jun, 23 | 15 | -16.67% |
| 31 Mar, 23 | 18 | -25.00% |
| 31 Dec, 22 | 24 | 9.09% |
| 30 Sep, 22 | 22 | -8.33% |
| 30 Jun, 22 | 24 | 4.35% |
| 31 Mar, 22 | 23 | -17.86% |
| 31 Dec, 21 | 28 | -22.22% |
| 30 Sep, 21 | 36 | 176.92% |
| 30 Jun, 21 | 13 | -58.06% |
| 31 Mar, 21 | 31 | 181.82% |
| 31 Dec, 20 | 11 | -38.89% |
| 30 Sep, 20 | 18 | 50.00% |
| 30 Jun, 20 | 12 | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
18 institutional shareholders have reduced their position in BDTX stock as of 30 Jun 24 compared to 22 in the previous quarter (a -18.18% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 92 | 3.37% | 46,506,845 | 18.77% | 89.77% | 1.13% | 55 | 10.00% | 18 | -18.18% |
| 31 Mar, 24 | 89 | 15.58% | 39,156,127 | 2.72% | 89.08% | 1.59% | 50 | 31.58% | 22 | 10.00% |
| 31 Dec, 23 | 77 | - | 38,119,952 | 2.48% | 74.83% | 0.72% | 38 | - | 20 | 17.65% |
| 30 Sep, 23 | 77 | -3.75% | 37,195,825 | -8.55% | 101.86% | 0.82% | 38 | -19.15% | 17 | 13.33% |
| 30 Jun, 23 | 80 | 60.00% | 40,672,278 | 89.24% | 111.48% | 3.21% | 47 | 487.50% | 15 | -16.67% |
| 31 Mar, 23 | 50 | -15.25% | 21,491,972 | 2.08% | 58.91% | 1.76% | 8 | -61.90% | 18 | -25.00% |
| 31 Dec, 22 | 59 | -4.84% | 21,053,327 | -2.02% | 57.86% | 1.66% | 21 | - | 24 | 9.09% |
| 30 Sep, 22 | 62 | - | 21,488,446 | -0.06% | 59.12% | 1.68% | 21 | 16.67% | 22 | -8.33% |
| 30 Jun, 22 | 62 | -16.22% | 21,500,290 | -6.07% | 59.24% | 1.49% | 18 | -47.06% | 24 | 4.35% |
| 31 Mar, 22 | 74 | -15.91% | 22,889,468 | -1.33% | 63.11% | 1.54% | 34 | -10.53% | 23 | -17.86% |
| 31 Dec, 21 | 88 | -10.20% | 23,199,077 | -4.83% | 64.11% | 1.42% | 38 | 11.76% | 28 | -22.22% |
| 30 Sep, 21 | 98 | -4.85% | 24,375,326 | -4.03% | 67.30% | 1.37% | 34 | -46.03% | 36 | 176.92% |
| 30 Jun, 21 | 103 | -11.97% | 25,397,606 | -12.73% | 70.19% | 1.08% | 63 | 6.78% | 13 | -58.06% |
| 31 Mar, 21 | 117 | 6.36% | 29,102,784 | 1.70% | 80.57% | 1.07% | 59 | -23.38% | 31 | 181.82% |
| 31 Dec, 20 | 110 | 25.00% | 28,616,613 | 20.42% | 86.96% | 1.99% | 77 | 35.09% | 11 | -38.89% |
| 30 Sep, 20 | 88 | 10.00% | 23,763,219 | 2.71% | 66.14% | 1.59% | 57 | 14.00% | 18 | 50.00% |
| 30 Jun, 20 | 80 | 23.08% | 23,135,681 | 3.82% | 64.43% | 0.73% | 50 | -23.08% | 12 | - |
| 31 Mar, 20 | 65 | 6400.00% | 22,285,068 | 220982.02% | 94.03% | 9852877.02% | 65 | 6400.00% | - | - |
| 31 Dec, 19 | 1 | - | 10,080 | - | 0.03% | - | 1 | - | - | - |
Black Diamond Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Black Diamond Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 11 | - | - |
| Q1 2024 | 8 | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 6 | - | - |
| Q2 2023 | 13 | 1 | 1300.00% |
| Q1 2023 | 10 | - | - |
| Q4 2022 | 12 | - | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 33 | 2 | 1650.00% |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 2 | 8 | 25.00% |
| Q3 2021 | 3 | 7 | 42.86% |
| Q2 2021 | 17 | 11 | 154.55% |
| Q1 2021 | 18 | 28 | 64.29% |
| Q4 2020 | 72 | 219 | 32.88% |
| Q3 2020 | 55 | 52 | 105.77% |
| Q1 2020 | 52 | 34 | 152.94% |
11 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Black Diamond Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 2 | 1 | 200.00% |
| Q1 2023 | - | - | - |
| Q4 2022 | 8 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 10 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 6 | - |
| Q1 2021 | - | 17 | - |
| Q4 2020 | - | 163 | - |
| Q3 2020 | 1 | 14 | 7.14% |
| Q1 2020 | 14 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Black Diamond Therapeutics's stocks.
BDTX Ownership FAQ
Who Owns Black Diamond Therapeutics?
Black Diamond Therapeutics is owned by institutional shareholders (89.77%), insiders (2.33%), and public (7.91%). The largest institutional shareholder of Black Diamond Therapeutics is T. ROWE PRICE INVESTMENT MANAGEMENT, INC. (20.58% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.31% of total shares).
Who are the major institutional shareholders of Black Diamond Therapeutics?
Black Diamond Therapeutics's major institutional shareholders are T. ROWE PRICE INVESTMENT MANAGEMENT, INC., BELLEVUE GROUP AG, NEA MANAGEMENT COMPANY, LLC, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 55.93% of the company's share outstanding.
How many Black Diamond Therapeutics shareholders are there?
As of Jun 2024, there are 92 institutional shareholders of Black Diamond Therapeutics.
What percentage of Black Diamond Therapeutics is owned by T. ROWE PRICE INVESTMENT MANAGEMENT, INC?
T. ROWE PRICE INVESTMENT MANAGEMENT, INC owns 10.66M shares of Black Diamond Therapeutics, representing 20.58% of the company's total shares outstanding, valued at $49.68M (as of Jun 2024).
What percentage of Black Diamond Therapeutics is owned by BELLEVUE GROUP AG?
As of Jun 2024, BELLEVUE GROUP AG holds 8.52M shares of Black Diamond Therapeutics (BDTX), compromising 16.44% of the company, valued at $39.69M.
What percentage of Black Diamond Therapeutics is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC is the third largest holder of Black Diamond Therapeutics. The company owns 4.45M of the company's shares outstanding (worth $20.73M).